IP Library › Assignment 052425/0561
Patent Assignment
Reel/Frame 052425/0561

Assignment of Assignor's Interest

Recorded: 2020-04-17 Pages: 3
Assignor
DURING, MATTHEW
Executed: 2019-03-12
Assignee
OVID THERAPEUTICS INC.
1460 BROADWAY, NEW YORK, NEW YORK, 10036
Covered Property (1)
Use of (1S,3S)-3-Amino-4-(Difluoromethylidene) Cyclopentane-1-Carboxylic Acid and (S)-3-Amino-4-(Difluoromethylenyl)Cyclopent-1-Ene-1-Carboxylic Acid in the Treatment of Tinnitus, Acute Sensorineural Hearing Loss, Meniere's Disease, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder and Addiction
Application: 16/851,268 →
Publication: US 2020/0246293